Creative Planning - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q2 2017$2,000
+100.0%
161
+130.0%
0.00%
Q1 2017$1,000
-93.8%
70
-94.5%
0.00%
Q4 2016$16,000
-80.7%
1,270
-57.2%
0.00%
-100.0%
Q3 2016$83,000
-20.2%
2,9700.0%0.00%0.0%
Q2 2016$104,000
-2.8%
2,970
-23.8%
0.00%0.0%
Q1 2016$107,000
+3466.7%
3,900
+3800.0%
0.00%
Q4 2015$3,0000.0%1000.0%0.00%
Q3 2015$3,0001000.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q4 2016
NameSharesValueWeighting ↓
Empirical Capital Management, LLC 479,018$9,298,0008.38%
Rhenman & Partners Asset Management AB 1,174,411$22,795,0002.28%
Capital Investment Advisory Services, LLC 153,842$2,986,0001.40%
Cortina Asset Management, LLC 1,238,420$24,038,0001.12%
Investors Research Corp 92,027$1,786,0001.02%
Matarin Capital Management, LLC 697,387$13,536,282,0000.87%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 853,687$16,570,0000.59%
RICE HALL JAMES & ASSOCIATES, LLC 809,257$15,708,0000.56%
BROADVIEW ADVISORS LLC 156,700$3,042,0000.52%
FRONTIER CAPITAL MANAGEMENT CO LLC 3,535,217$68,619,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders